The CECOG website has been updated to reflect all abundant
and recent activities of CECOG.
This new website is still under construction. We apologize for any inconvenience
The Central European Cooperative Oncology Group (CECOG)
has been formed to unite centers of clinical oncology from Central
and Southeastern Europe as well as Israel into a united body
devoted to the conduct of clinical trials and provide postgraduate education
in oncology.
We, the Scientific Board and the members of CECOG, state that we want to design and conduct controlled clinical trials in the field of clinical oncology according to guidelines defined by Good Clinical Practice, perform trials diligently and meticulously and analyze their results with utmost scientific care.
We declare to interact with the highest esteem for each other
and
with
the constant aim to ameliorate the well-being and fate of
our patients
History and members of CECOG »
Upcoming Events
Recent Publications
The Journal of Clinical Oncology has recently published an article on "Clinical Cancer Advances 2009: Marjor Research Advances in Cancer Treatment, Prevention and Screening - A Report from the American Society of Clinical Oncology" (N. Petrelli et al., Epub ahead of print, November 6, 2009).CECOG is proud that the JMEN trial - which was cosponsored by CECOG - is mentioned in this publication as having changed the standard of care in patients with non small cell lung cancer.
This study was published recently in The Lancet (T. Ciuleanu, T. Brodowicz, C. Zielinski, et al.: Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study. Lancet 2009; 374:1432-40).
Significant Prolongation of Overall Survival in Non Small Cell Lung Cancer by Maintenance Therapy with Pemetrexed: Participation of the Central European Cooperative Oncology Group (CECOG) in the Formulation of a New Treatment Concept.
continue »
Signifikante Verlängerung der Überlebensdauer bei Lungenkarzinom durch neue Therapiestrategie: Beteiligung der Central European Cooperative Oncology Group (CECOG) an der Erarbeitung eines neuen Behandlungskonzepts.
weiter »